$LPCN
Lipocine Inc.
XNAS•Health Care•Pharmaceutical Preparations
$1.98
▼-10.00%-$0.220
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateFlagged at $2.44 at 06:29 AM on Oct 07, then ran to $3.15 +29% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is LPCN down today? It is at $1.98 (-10.00%), and our scanner flagged it 38 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LPCN spikes, and full due diligence on LPCN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LPCN 38 times in the last 30 days. Create a free account to track $LPCN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
LPCN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on LPCN today. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Higuchi John W. Director | Bought (open market) | +16K 0.2% of company | added 7.1% | 241K | $36K at $2.23 | Sep 30, 26 |
Higuchi John W. Director | Bought (open market) | +9K 0.1% of company | added 4.2% | 225K | $19K at $2.15 | Sep 29, 26 |
Higuchi John W. Director | Bought (open market) | +13K 0.2% of company | added 6.2% | 216K | $27K at $2.16 | Sep 28, 26 |
Higuchi John W. Director | Bought (open market) | +40K 0.5% of company | added 24% | 204K | $81K at $2.03 | Apr 7, 26 |
Patel Mahesh V. Officer | Bought (open market) | +25K 0.3% of company | added 18% | 161K | $51K at $2.03 | Apr 6, 26 |
Higuchi John W. Director | Bought (open market) | +123K 1.5% of company | added 100% | 164K | $252K at $2.05 | Apr 6, 26 |
Patel Mahesh V. Officer | Bought (open market) | +25K 0.3% of company | added 23% | 136K | $51K at $2.02 | Apr 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
LPCN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on LPCN today. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
LPCN last traded at $1.98, down 10.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Lipocine Inc. (LPCN) is next expected to report earnings on Thursday, November 5, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LPCN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LPCN 38 times in the last 30 days.
LPCN (Lipocine Inc.) trades on XNAS, with a market cap of about $18M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LPCN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LPCN discussion
Sign in to ask a question or join the discussion.